Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns

Authors

Yi Dong, Department of Neurology, Huashan Hospital Fudan University, Shanghai, China.
Yi Sui, Department of Neurology, Shenyang Brain Hospital, Shenyang Medical College, Shenyang, China.
Xin Cheng, Department of Neurology, Huashan Hospital Fudan University, Shanghai, China.
David Z. Wang, Department of Neurology, Barrow Neurological Institute, Phoenix, Arizona, USA david.wang@dignityhealth.org.Follow

Document Type

Editorial

Medical Subject Headings

Brain Ischemia (diagnosis, drug therapy); Humans; Ischemic Stroke (diagnosis, drug therapy); Stroke (diagnosis, drug therapy); Tenecteplase (adverse effects); Tissue Plasminogen Activator (adverse effects)

Publication Date

2-1-2022

Publication Title

Stroke and vascular neurology

E-ISSN

2059-8696

Volume

7

Issue

1

First Page

1

Last Page

5

PubMed ID

34667106

Digital Object Identifier (DOI)

10.1136/svn-2021-001321

Recommended Citation

Dong, Yi; Sui, Yi; Cheng, Xin; and Wang, David Z., "Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns" (2022). Neurology. 1799.
https://scholar.barrowneuro.org/neurology/1799